Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: Roland Chen who wrote (828)	1/11/1998 11:45:00 PM
From: Charles Holewinski	Respond to of 1115

Roland, The thought of shorting BI's recommendations sounds like a real money maker!

To: Roland Chen who wrote (828)	1/13/1998 5:06:00 AM
From: John Zwiener	Read Replies (3) \| Respond to of 1115

To all, most of the good Lidak discussion is on the Yahoo msgs. If you start at post 177, or maybe a little earlier, and follow the next 50 posts, you will find many good posts, and a few wierd ones. Of interest is the participation of Henry Niman, who for some reason spent some time commenting, and learning about what is going on (he still has a way to go). Mentioned he thinks lidakol will be approved despite somewhat a somewhat guarded outlook. I think he is looking at it since lidak has a kaposi's trial going on (so does ligand, his favorate stock). Also, there are other decent posters participating, just enjoy the occasonal wild poster. Not sure why the lidak discussion ended up on Yahoo. I like the SI format better. Here's the link. messages.yahoo.com